Bruker (NASDAQ:BRKR) Stock Price Up 3.6% – What’s Next?

Posted by Brenda Bartman on Sep 26th, 2026

Bruker Corporation (NASDAQ:BRKR – Get Free Report) traded up 3.6% during mid-day trading on Thursday. The company traded as high as $60.82 and last traded at $61.8050. Approximately 70,144 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 2,355,954 shares. The stock had previously closed at $59.67.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Stifel Nicolaus set a $50.00 price objective on shares of Bruker in a research report on Wednesday, August 5th. Citigroup cut their price target on Bruker from $60.00 to $53.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Zacks Research cut Bruker from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 2nd. Guggenheim boosted their price objective on Bruker from $50.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, June 29th. Finally, UBS Group assumed coverage on Bruker in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $65.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $57.00.

Check Out Our Latest Stock Report on Bruker

Bruker Stock Up 0.3%

The company has a debt-to-equity ratio of 0.76, a current ratio of 1.85 and a quick ratio of 0.92. The company’s 50-day simple moving average is $58.48 and its 200 day simple moving average is $50.72. The firm has a market cap of $9.78 billion, a P/E ratio of -91.69, a price-to-earnings-growth ratio of 1.96 and a beta of 1.26.

Bruker (NASDAQ:BRKR – Get Free Report) last posted its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. The firm had revenue of $838.50 million for the quarter, compared to the consensus estimate of $853.57 million. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Research analysts anticipate that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, September 21st. Bruker’s payout ratio is presently -28.57%.

Insider Transactions at Bruker

In other Bruker news, VP Mark Munch sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $52.87, for a total transaction of $105,740.00. Following the sale, the vice president directly owned 134,806 shares in the company, valued at $7,127,193.22. This represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 27.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Bruker

Several large investors have recently modified their holdings of the stock. Sequoia Financial Advisors LLC bought a new stake in shares of Bruker in the 2nd quarter worth about $250,000. Tidal Investments LLC boosted its stake in shares of Bruker by 180.4% during the second quarter. Tidal Investments LLC now owns 29,092 shares of the medical research company’s stock valued at $1,751,000 after purchasing an additional 18,715 shares during the period. WINTON GROUP Ltd bought a new position in shares of Bruker in the second quarter worth about $344,000. Engineers Gate Manager LP increased its stake in Bruker by 141.8% in the 2nd quarter. Engineers Gate Manager LP now owns 56,825 shares of the medical research company’s stock worth $3,420,000 after buying an additional 33,329 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new stake in Bruker during the 2nd quarter valued at about $445,000. Institutional investors own 79.52% of the company’s stock.

About Bruker

(Get Free Report)

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.